Clinical Trial Update: Nimotuzumab in Combination With TPF(Cisplatin ,Fluorouracil and Docetaxel) for Head and Neck Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase II trial of Nimotuzumab in combination with TPF chemotherapy for head and neck squamous cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Wei Guo | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED